Ring Christine
Chief Legal Officer | General Counsel
1 company
Insider Signal Score
77
ExcellentTrades Analyzed
48
12M Win Rate
88.1%
Avg 3M Return
+2.5%
Avg 12M Return
+30.5%
Ring Christine is a Chief Legal Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $230K based on current market prices.
Holdings by Company
NRIX4d ago
Current Shares9.1K
Value$229.8K
Net Activity-246,323
Bought: 0Sold: 246.3K
Transaction History
Showing 10 filings (page 4)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 1,596 | $17.01 | $27,152.91 | -7.4% | +54.9% | -24.7% | |
| Apr 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 1,513 | $12.04 | $18,219.85 | -7.1% | +76.8% | -4.1% | |
| Jan 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 1,760 | $7.99 | $14,062.75 | -9.2% | +56.1% | +145.9% | |
| Oct 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 1,232 | $5.20 | $6,403.20 | -7.5% | +49.7% | +330.6% | |
| Jul 31, 2023 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,420 | $9.65 | $13,709.67 | -10.2% | -45.8% | +113.9% | |
| May 1, 2023 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 682 | $9.88 | $6,735.64 | -6.4% | -1.9% | +21.4% | |
| Jan 30, 2023 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 848 | $11.78 | $9,989.10 | -10.5% | -16.6% | -32.7% | |
| Oct 31, 2022 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 699 | $12.88 | $9,003.47 | -10.2% | -6.8% | -56.1% | |
| Aug 1, 2022 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 712 | $15.67 | $11,157.04 | -13.4% | -17.4% | -38.4% | |
| May 2, 2022 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 660 | $11.75 | $7,755.00 | -16.2% | +28.8% | -21.4% |